Jacobs Levy Equity Management Inc. Sells 908 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Jacobs Levy Equity Management Inc. reduced its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 0.7% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 137,720 shares of the company’s stock after selling 908 shares during the quarter. Jacobs Levy Equity Management Inc. owned approximately 0.84% of Addus HomeCare worth $14,232,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of ADUS. Lord Abbett & CO. LLC bought a new position in Addus HomeCare in the 1st quarter worth $8,274,000. Allianz Asset Management GmbH bought a new position in Addus HomeCare in the 4th quarter worth $5,667,000. Vanguard Group Inc. raised its holdings in Addus HomeCare by 4.9% in the 3rd quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock worth $103,809,000 after purchasing an additional 57,040 shares during the period. Assenagon Asset Management S.A. raised its holdings in Addus HomeCare by 78.8% in the 1st quarter. Assenagon Asset Management S.A. now owns 112,256 shares of the company’s stock worth $11,601,000 after purchasing an additional 49,483 shares during the period. Finally, Janus Henderson Group PLC raised its holdings in Addus HomeCare by 683.7% in the 1st quarter. Janus Henderson Group PLC now owns 55,188 shares of the company’s stock worth $5,703,000 after purchasing an additional 48,146 shares during the period. 95.35% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 4.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on ADUS shares. Macquarie started coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price target for the company. Stephens increased their price target on Addus HomeCare from $120.00 to $128.00 and gave the stock an “overweight” rating in a research note on Friday, May 31st. Bank of America increased their price target on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. Barclays lowered Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target for the company. in a research note on Tuesday, April 23rd. Finally, StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. One equities research analyst has rated the stock with a sell rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $116.25.

Addus HomeCare Price Performance

Shares of ADUS stock traded down $0.10 during trading hours on Wednesday, hitting $121.37. The stock had a trading volume of 25,323 shares, compared to its average volume of 134,544. Addus HomeCare Co. has a one year low of $78.35 and a one year high of $125.24. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.35 and a quick ratio of 1.35. The stock’s 50-day moving average price is $117.40 and its two-hundred day moving average price is $104.18. The stock has a market capitalization of $2.20 billion, a price-to-earnings ratio of 29.93, a PEG ratio of 2.37 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The firm had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. During the same period in the previous year, the firm posted $0.84 earnings per share. The business’s revenue was up 11.6% compared to the same quarter last year. Equities analysts forecast that Addus HomeCare Co. will post 4.36 EPS for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.